Buckingham Strategic Wealth, LLC Pa Vmed Inc. Transaction History

Buckingham Strategic Wealth, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$0.57 - $34.65 $5,187 - $315,315	9,100 Added 14.94%	70,000 $60,000
Q4 2021 Feb 09, 2022	BUY	$2.46 - $8.74 $68,634 - $243,846	27,900 Added 84.55%	60,900 $150,000
Q3 2021 Nov 10, 2021	SELL	$5.1 - $9.39 $51,000 - $93,900	-10,000 Reduced 23.26%	33,000 $282,000
Q2 2021 Aug 06, 2021	SELL	$3.95 - $6.88 $35,893 - $62,518	-9,087 Reduced 17.45%	43,000 $275,000
Q1 2021 Apr 30, 2021	BUY	$2.01 - $5.55 $18,089 - $49,950	9,000 Added 20.89%	52,087 $231,000
Q4 2020 Feb 16, 2021	BUY	$1.73 - $2.13 $3,460 - $4,260	2,000 Added 4.87%	43,087 $91,000
Q2 2020 Aug 03, 2020	BUY	$1.75 - $2.65 $1,902 - $2,880	1,087 Added 2.72%	41,087 $87,000
Q1 2020 May 07, 2020	BUY	$1.15 - $3.29 $46,000 - $131,600	40,000 New	40,000 $79,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $92.8M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Buckingham Strategic Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Buckingham Strategic Wealth, LLC with notifications on news.